Abstract
Nociceptin-immunoreactive cellbodies were detected in the human trigeminal ganglion, while no such fibers were identified in the temporal artery or in dermal tissue from the neck region. In four healthy subjects receiving nociceptin into the temporal muscle in an open labeled design no pain was detected. In 10 healthy subjects who received 200pmol of nociceptin into tender non-dominant trapezius muscles in a placebo-controlled, randomized, balanced, and double-blinded design local tenderness increased (P=0.025) while no pain was noted. Thus, the action of nociceptin should be searched for in the trigeminal ganglion and/or in the central nervous system (CNS).
| Original language | English |
|---|---|
| Journal | Peptides |
| Volume | 23 |
| Issue number | 9 |
| Pages (from-to) | 1581-7 |
| Number of pages | 7 |
| ISSN | 0196-9781 |
| Publication status | Published - Sept 2002 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Double-Blind Method
- Facial Pain
- Female
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Muscles
- Opioid Peptides
- Pain
- Pain Threshold
- Placebos
- Receptors, Opioid
- Time Factors
- Trigeminal Ganglion
- Vasodilator Agents
Fingerprint
Dive into the research topics of 'Does nociceptin play a role in pain disorders in man?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS